Story

Cape Bio Pharms is an exciting new (ad)venture based in Cape Town, South Africa. They are a spin-off company of the University of Cape Town aimed at commercialising the biotech developed by the Biopharming Research Unit (BRU) for the production of recombinant proteins in tobacco (actually a distant cousin of the tobacco plant).

Their product pipeline focuses on a wide range of research reagents such as antibodies, fusion proteins, peptides and enzymes. All are critical research tools for life scientists around the world in search of new drugs to treat the onslaught of human and animal diseases.

Their Custom Protein Service offers life scientists the opportunity of 'doing it in plants'. Plant-based expressions allows us to quickly and economically produce proof-of-concept trials from microgram to gram quantities. 'Doing it in plants' is an ethical alternative as they do not use animals in the making of their antibodies.

Their team is a passionate group of postgraduates from multiple disciplines such as Molecular & Cell Biology, Medical Biochemistry and Human and Cell Biology.